THC Farmaceuticals, Inc. engages in the research and development of cannabis pharmaceutical products. The company is headquartered in Scottsdale, Arizona and currently employs 2 full-time employees. The company went IPO on 2012-08-22. The firm specializes in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology and other medical disciplines. The company offers the combination of its proprietary developments with its clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds. The firm owns clinical research center and cannabidiol (CBD) manufacturing facility in California. Its business plan includes conducting cannabinoids research and development in collaboration with cannabis research centers worldwide with the goal of developing novel and advanced therapeutic methods for the treatment of common medical conditions with cannabis-based therapies and to conduct pre-clinical investigations and randomized, placebo-controlled trials of CBD-based compounds and develop condition-specific medications. The company offers a network of micro vending kiosk systems.
Follow-Up Questions
What is THC Farmaceuticals Inc (CBDG)'s P/E Ratio?
The P/E ratio of THC Farmaceuticals Inc is 0.9768
What is the price performance of CBDG stock?
The current price of CBDG is $0.013, it has decreased 0% in the last trading day.
What are the primary business themes or industries for THC Farmaceuticals Inc?
THC Farmaceuticals Inc belongs to Commercial Services & Supplies industry and the sector is Industrials
What is THC Farmaceuticals Inc market cap?
THC Farmaceuticals Inc's current market cap is $235.6K
